Ceftobiprole in the Treatment of Patients With Staphylococcus Aureus Bacteremia

Condition:   Staphylococcus Aureus Bacteremia Interventions:   Drug: Ceftobiprole medocaril;   Drug: Daptomycin Sponsors:   Basilea Pharmaceutica;   Department of Health and Human Services Not yet recruiting - verified April 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials